Related references
Note: Only part of the references are listed.Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
V Subbiah et al.
ANNALS OF ONCOLOGY (2022)
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive Chemoradiotherapy
Robert W. Gao et al.
PRACTICAL RADIATION ONCOLOGY (2022)
Limited efficacy of lenvatinib in heavily pretreated anaplastic thyroid cancer: a French overview
Clotilde Sparano et al.
ENDOCRINE-RELATED CANCER (2021)
Primary Versus Secondary Anaplastic Thyroid Carcinoma: Perspectives from Multi-institutional and Population-Level Data
Tam N. M. Ngo et al.
ENDOCRINE PATHOLOGY (2021)
M2-like tumor-associated macrophages-secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating β-catenin pathway in thyroid cancer
Juan Lv et al.
MOLECULAR CARCINOGENESIS (2021)
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
Christine Dierks et al.
THYROID (2021)
Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study
Weili Zhou et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer
Lori J. Wirth et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer American Thyroid Association Anaplastic Thyroid Cancer Guidelines Task Force
Keith C. Bible et al.
THYROID (2021)
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment
Pascal K. C. Jonker et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
Pia Adam et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
Alessandro Prete et al.
CANCERS (2021)
Benefits of pembrolizumab in progressive radioactive iodine refractory thyroid cancer: Results of the AcSe Pembrolizumab Study from Unicancer.
Sophie Leboulleux et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The prevalence of DNA microsatellite instability in anaplastic thyroid carcinoma - systematic review and discussion of current therapeutic options
Maria Linda Rocha et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2021)
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma
Wei Wang et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2021)
Anaplastic thyroid cancer: outcomes of trimodal therapy
Orla A. Houlihan et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2021)
PAX8 expression in anaplastic thyroid carcinoma is less than those reported in early studies: a multi-institutional study of 182 cases using the monoclonal antibody MRQ-50
Wei-An Lai et al.
VIRCHOWS ARCHIV (2020)
Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
Naoyoshi Onoda et al.
CANCERS (2020)
Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades
Mischa de Ridder et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Atezolizumab combinations with targeted therapy for anaplastic thyroid carcinoma (ATC).
Maria E. Cabanillas et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
PD-1 Blockade in Anaplastic Thyroid Carcinoma
Jaume Capdevila et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors
Maria E. Cabanillas et al.
THYROID (2020)
Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases
Bin Xu et al.
THYROID (2020)
Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma
Dora Dias-Santagata et al.
THYROID (2020)
Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019
Anastasios Maniakas et al.
JAMA ONCOLOGY (2020)
Larotrectinib treatment of advanced TRK fusion thyroid cancer
M. E. Cabanillas et al.
ANNALS OF ONCOLOGY (2020)
Randomized phase II study of radiation therapy and paclitaxel with pazopanib or placebo: NRG-RTOG 0912
E. J. Sherman et al.
ANNALS OF ONCOLOGY (2020)
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization
Ying-Hsia Chu et al.
MODERN PATHOLOGY (2020)
Multimodal treatment based on thyroidectomy improves survival in patients with metastatic anaplastic thyroid carcinoma: a SEER analysis from 1998 to 2015
Tao Song et al.
GLAND SURGERY (2020)
Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU)
Paolo G. Casali et al.
ESMO OPEN (2020)
Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like
Riccardo Giannini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas
Kristine S. Wong et al.
THYROID (2019)
An Update of the Appropriate Treatment Strategies in Anaplastic Thyroid Cancer: A Population-Based Study of 735 Patients
Nai-si Huang et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2019)
Identification of Targetable Lesions in Anaplastic Thyroid Cancer by Genome Profiling
Naveen Ravi et al.
CANCERS (2019)
Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
Christian M. Schurch et al.
THYROID (2019)
The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Yuan Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma
Jennifer R. Wang et al.
THYROID (2019)
Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer
Seong-Keun Yoo et al.
NATURE COMMUNICATIONS (2019)
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Filetti et al.
ANNALS OF ONCOLOGY (2019)
A Phase II study of the safety and efficacy oflenvatinib in patients with advanced thyroidcancer
Shunji Takahashi et al.
FUTURE ONCOLOGY (2019)
EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC
Gnana P. Krishnamoorthy et al.
CANCER DISCOVERY (2019)
Hypofractionated Radiotherapy for Anaplastic Thyroid Carcinoma: 15 Years of Experience in a Single Institution
Noriyoshi Takahashi et al.
EUROPEAN THYROID JOURNAL (2019)
Early evolutionary divergence between papillary and anaplastic thyroid cancers
J. Capdevila et al.
ANNALS OF ONCOLOGY (2018)
Anaplastic thyroid carcinoma in Denmark 1996-2012: A national prospective study of 219 patients
Gitte Bjorn Hvilsom et al.
CANCER EPIDEMIOLOGY (2018)
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Nikita Pozdeyev et al.
CLINICAL CANCER RESEARCH (2018)
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer
Vivek Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Gene Fusions in Thyroid Cancer
Valentina D. Yakushina et al.
THYROID (2018)
Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma
Maria E. Cabanillas et al.
THYROID (2018)
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
Cristina Romei et al.
ONCOLOGY LETTERS (2018)
Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
Priyanka C. Iyer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Unusually long-term responses to vemurafenib in BRAF V600E mutated colon and thyroid cancers followed by the development of rare RAS activating mutations
Tali Ofir Dovrat et al.
CANCER BIOLOGY & THERAPY (2018)
Hgf/Met activation mediates resistance to BRAF inhibition in murine anaplastic thyroid cancers
Jeffrey A. Knauf et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
1821PDUpdated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E–mutated anaplastic thyroid cancer (ATC)
B Keam et al.
ANNALS OF ONCOLOGY (2018)
Treatment outcomes of radiotherapy for anaplastic thyroid cancer
Jong Won Park et al.
RADIATION ONCOLOGY JOURNAL (2018)
Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base
Todd A. Pezzi et al.
CANCER (2017)
Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma
P. Jimenez-Fonseca et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012
Seung-Kuk Baek et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial
Tatiana C. Schneider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery
Anne-Birgitte Jacobsen et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2017)
Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer
Maria E. Cabanillas et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer
Naiyarat Prasongsook et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study
Ashish V. Chintakuntlawar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
Benjamin Lacas et al.
LANCET ONCOLOGY (2017)
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
Eleonora Molinaro et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases
Benjamin Bonhomme et al.
THYROID (2017)
Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma
Sarika N. Rao et al.
THYROID (2017)
External beam radiotherapy in thyroid carcinoma: clinical review and recommendations of the AIRO Radioterapia Metabolica Group
Monica Mangoni et al.
TUMORI JOURNAL (2017)
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
Takuro Noguchi et al.
CANCER IMMUNOLOGY RESEARCH (2017)
External beam radiotherapy in thyroid carcinoma: clinical review and recommendations of the AIRO Radioterapia Metabolica Group
Monica Mangoni et al.
TUMORI JOURNAL (2017)
Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer
Eric J. Sherman et al.
CANCER (2017)
Anaplastic Transformation of Papillary Thyroid Carcinoma Only Seen in Pleural Metastasis: A Case Report with Review of the Literature
Hyunsung Kim et al.
HEAD & NECK PATHOLOGY (2017)
Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy
H. Vulpe et al.
CURRENT ONCOLOGY (2017)
The role of surgery in anaplastic thyroid cancer: A systematic review
Shirley Hu et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2017)
The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis
Jeanny Kwon et al.
EUROPEAN JOURNAL OF CANCER (2016)
Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany
Julia Wendler et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival
Scott M. Glaser et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer
Jill J. Bastman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases
Tian-Run Liu et al.
PLOS ONE (2016)
The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective Study
Naoyoshi Onoda et al.
THYROID (2016)
Anaplastic Thyroid Carcinoma: Treatment in the Age of Molecular Targeted Therapy
Maria E. Cabanillas et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing
John W. Kunstman et al.
HUMAN MOLECULAR GENETICS (2015)
Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma
Yann Godbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
18F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer
Antonin Levy et al.
ORAL ONCOLOGY (2015)
Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma
Yuval Nachalon et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2015)
Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases
Akira Seto et al.
SURGERY TODAY (2015)
Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates
Kyong Yeun Jung et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2015)
Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma
Xiayun He et al.
BMC CANCER (2014)
Long-term results of radiotherapy in anaplastic thyroid cancer
Anne-Katrin Dumke et al.
RADIATION ONCOLOGY (2014)
Early Surgery and Survival of Patients with Anaplastic Thyroid Carcinoma: Analysis of a Case Series Referred to a Single Institution Between 1999 and 2012
Enrico Brignardello et al.
THYROID (2014)
Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
Moira Ragazzi et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Comparing outcomes in poorly-differentiated versus anaplastic thyroid cancers treated with radiation: A surveillance, epidemiology, and end results analysis
Shruthi Arora et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2014)
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes
S. M. Lim et al.
ANNALS OF ONCOLOGY (2013)
Marginal treatment benefit in anaplastic thyroid cancer
Megan R. Haymart et al.
CANCER (2013)
Indications of external beam radiation therapy in non-anaplastic thyroid cancer and impact of innovative radiation techniques
X. S. Sun et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression
Mabel Ryder et al.
PLOS ONE (2013)
Recent Trends in the Incidence, Geographical Distribution, and Survival From Thyroid Cancer in Wales, 1985-2010
Bethan Amphlett et al.
THYROID (2013)
Multimodality therapeutic outcomes In anaplastic thyroid carcinoma: Improved survival in subgroups of patients with localized primary tumors
Ken-ichi Ito et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Approach to the Patient with Anaplastic Thyroid Carcinoma
Robert C. Smallridge
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The Role of External Beam Radiation and Targeted Therapy in Thyroid Cancer
James Brierley et al.
SEMINARS IN RADIATION ONCOLOGY (2012)
Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer
Julie A. Sosa et al.
SURGERY (2012)
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Robert C. Smallridge et al.
THYROID (2012)
Prognostic Factors and Treatment Outcomes for Anaplastic Thyroid Carcinoma: ATC Research Consortium of Japan Cohort Study of 677 Patients
Iwao Sugitani et al.
WORLD JOURNAL OF SURGERY (2012)
Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
Sun Min Lim et al.
YONSEI MEDICAL JOURNAL (2012)
Results of combined treatment of anaplastic thyroid carcinoma (ATC)
Olfa Derbel et al.
BMC CANCER (2011)
PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck
Justin A. Bishop et al.
HUMAN PATHOLOGY (2011)
Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma
Bernard Caillou et al.
PLOS ONE (2011)
Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: A critical re-evaluation including uniform pathologic review
Eric J. Sherman et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Prognostic Factors and Treatment Outcomes of 100 Cases of Anaplastic Thyroid Carcinoma
Junko Akaishi et al.
THYROID (2011)
Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
R. C. Smallridge et al.
CLINICAL ONCOLOGY (2010)
ANAPLASTIC THYROID CANCER: CLINICAL OUTCOMES WITH CONFORMAL RADIOTHERAPY
Aarti Bhatia et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer
Tae Hyun Kim et al.
RADIATION ONCOLOGY (2010)
Induction Chemotherapy with Weekly Paclitaxel Administration for Anaplastic Thyroid Carcinoma
Takuya Higashiyama et al.
THYROID (2010)
Multimodality treatment for anaplastic thyroid carcinoma - Treatment outcome in 75 patients
Annemarie T. Swaak-Kragten et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Surgery and Radiotherapy Improves Survival in Patients With Anaplastic Thyroid Carcinoma
Jergin Chen et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
Mabel Ryder et al.
ENDOCRINE-RELATED CANCER (2008)
Anaplastic thyroid cancer and primary thyroid lymphoma: A review of these rare thyroid malignancies
Lawrence D. Green et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens
Yongjin Wang et al.
CANCER (2006)
Anaplastic thyroid carcinoma: Biology, pathogenesis, prognostic factors, and treatment approaches
C Are et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Anaplastic thyroid carcinoma: A therapeutic dilemma
HS Chang et al.
YONSEI MEDICAL JOURNAL (2005)
Anaplastic thyroid carcinoma - Treatment outcome and prognostic factors
E Kebebew et al.
CANCER (2005)
Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy
R De Crevoisier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Anaplastic thyroid carcinoma:: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery
J Tennvall et al.
BRITISH JOURNAL OF CANCER (2002)
Anaplastic thyroid carcinoma: A 50-year experience at a single institution
B McIver et al.
SURGERY (2001)
Effect of primary treatment on survival in anaplastic thyroid carcinoma
N Besic et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
β-Catenin dysregulation in thyroid neoplasms -: Down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis
G Garcia-Rostan et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Dose optimization for the treatment of anaplastic thyroid carcinoma: A comparison of treatment planning techniques
MD Posner et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
